Use of trastuzumab for the treatment of early stage breast cancer.

Use of trastuzumab for the treatment of early stage breast cancer.

Item
http://www.wikidata.org/entity/Q36573813
Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.Can molecular subtyping replace axillary nodal status as prognostic marker in breast cancer?EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy.Evaluation of HER2 in breast cancer: reality and expectations.A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells.Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland.Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy - a Prospective Clinical Study.
P2860

Use of trastuzumab for the treatment of early stage breast cancer.

Item
http://www.wikidata.org/entity/Q36573813
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Use of trastuzumab for the treatment of early stage breast cancer.
@ast
Use of trastuzumab for the treatment of early stage breast cancer.
@en
type
label
Use of trastuzumab for the treatment of early stage breast cancer.
@ast
Use of trastuzumab for the treatment of early stage breast cancer.
@en
prefLabel
Use of trastuzumab for the treatment of early stage breast cancer.
@ast
Use of trastuzumab for the treatment of early stage breast cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Use of trastuzumab for the treatment of early stage breast cancer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698